AB-CHMINACA
|
- $90 - $2369
- Product name: AB-CHMINACA
- CAS: 1185887-21-1
- MF: C20H28N4O2
- MW: 356.46
- EINECS:-0
- MDL Number:
- Synonyms:AB-CHMINACA;N-[(1S)-1-(AMINOCARBONYL)-2-METHYLPROPYL]-1-(CYCLOHEXYLMETHYL)-1H-INDAZOLE-3-CARBOXAMIDE;AB-CHMINACA 3-Methyl butanoic Acid;ABCH;AB-CHMINACA (exempt preparation);N-[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]-1-(cyclohexylmethyl)indazole-3-carboxamide;AMB N-methylcyclohexyl analog;MAB-AB-CHMINACA
4 prices
Selected condition：
Brand
- Biosynth
- Cayman Chemical
Package
- 1mg
- 5mg
- 100mg
- ManufacturerBiosynth
- Product numberFA64684
- Product descriptionAB-CHMINACA
- Packaging100mg
- Price$2369
- Updated2026-06-04
- Buy
- ManufacturerCayman Chemical
- Product number15434
- Product descriptionAB-CHMINACA ≥98%
- Packaging1mg
- Price$90
- Updated2026-04-30
- Buy
- ManufacturerCayman Chemical
- Product number27237
- Product descriptionAB-CHMINACA (CRM)
- Packaging1mg
- Price$208
- Updated2026-04-30
- Buy
- ManufacturerCayman Chemical
- Product number15434
- Product descriptionAB-CHMINACA ≥98%
- Packaging5mg
- Price$219
- Updated2026-04-30
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Biosynth | FA64684 | AB-CHMINACA | 100mg | $2369 | 2026-06-04 | Buy |
| Cayman Chemical | 15434 | AB-CHMINACA ≥98% | 1mg | $90 | 2026-04-30 | Buy |
| Cayman Chemical | 27237 | AB-CHMINACA (CRM) | 1mg | $208 | 2026-04-30 | Buy |
| Cayman Chemical | 15434 | AB-CHMINACA ≥98% | 5mg | $219 | 2026-04-30 | Buy |
Properties
Boiling point :625.8±35.0 °C(Predicted)
Density :1.27±0.1 g/cm3(Predicted)
solubility :DMF: 5 mg/ml; DMSO: 10 mg/ml; DMSO:PBS(pH7.2) (1:1): 0.5 mg/ml; Ethanol: 3 mg/ml
form :A neat solid
pka :11.37±0.46(Predicted)
Density :1.27±0.1 g/cm3(Predicted)
solubility :DMF: 5 mg/ml; DMSO: 10 mg/ml; DMSO:PBS(pH7.2) (1:1): 0.5 mg/ml; Ethanol: 3 mg/ml
form :A neat solid
pka :11.37±0.46(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|
Description
AB-FUBINACA is an indazole-based synthetic cannabinoid (CB) with 10-fold greater affinity for the central CB1 receptor (Ki = 0.9 nM) than that of JWH 018 . AB-FUBINACA was first synthesized by Pfizer, Inc. as a potent CB1 receptor modulator for potential therapeutic use, but recently was identified along with AB-PINACA in illegal herbal products. AB-CHMINACA is structurally related to AB-FUBINACA with a cyclohexyl group substituted for the 4-fluorophenyl group. The physiological and toxicological properties of this compound have not been determined. This product is intended for research and forensic applications.More related product prices
AB-CHMINACA metabolite M4-d4 (CRM) AB-CHMINACA APP-CHMINACA AB-CHMINACA-d4 (CRM) AB-FUBINACA MAB-CHMINACARelated product price
-
AB-CHMINACA metabolite M4-d4 (CRM)
$81-691 -
AB-CHMINACA
$90-2369 -
APP-CHMINACA
$90-2118